AFX Carl Zeiss Meditec AG

35.38USD32.26 EUR · XETRA0.00%Mkt Cap: 3.10B USDP/E: 23.21

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products a…

Institutional holders11 on file

Key Statistics

Company
Market Cap3.10B USD
Enterprise Value3.67B USD
Revenue (TTM)2.39B USD
Gross Profit1.29B USD
Net Income (TTM)154.88M USD
Revenue/Share27.45 USD
Last Price35.38 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees5.8K
CountryDE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINDE0005313704
Valuation
P/E (Trailing)23.21
P/E (Forward)22.10
PEG1.18
EV/EBITDA15.38
EV/Revenue1.54
P/S1.29
P/B1.35
EPS (TTM)1.52 USD
EPS (Forward)1.60 USD
52W Range
24.8140% of range51.05
52W High51.05 USD
52W Low24.81 USD
Profitability
Gross Margin52.76%
Oper. Margin7.23%
EBITDA Margin9.99%
Profit Margin6.34%
ROE6.67%
ROA4.15%
ROIC7.34%
ROCE7.81%
Growth
Revenue Growth2.40%
Earnings Growth97.50%
Cash Flow & Leverage
Operating CF230.17M USD
CapEx (TTM)84.01M USD
FCF Margin—
FCF Yield—
Net Debt610.98M USD
Net Debt/EBITDA2.56
Net Debt/FCF—
Balance Sheet
Debt/Equity0.06
Current Ratio—
Quick Ratio—
Book Value/Sh26.30 USD
Cash/Share0.30 USD
Dividends
Fwd Div Rate0.60 USD
Trail. Div Rate0.60 USD
Div. Yield1.60%
5Y Avg Yield0.97%
Payout Ratio39.57%
Ex-Div DateMar 27, 2026
Pay Date—
Analyst Consensus
Rating3.8 (Underperform)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)29.46 USD
Upside (mean)-16.7%
Target Range19.85 USD – 38.39 USD
19.85-16.7% to mean38.39
# Analysts15
Ownership
Shares Out.87.54M
Float34.19M
Insiders59.14%
Institutions19.87%
Technical
SMA 5035.89 (-1.4%)
SMA 20031.47 (+12.4%)
Beta1.35
S&P 52W Chg12.00%
Avg Vol (30d)140.45K
Avg Vol (10d)122.78K
Technical Indicators
RSI (14)37.7
MACD0.0659
MACD Signal0.4612
MACD Hist.-0.3954
BB Upper40.11 USD
BB Middle37.98 USD
BB Lower35.85 USD
BB Width11.21%
ATR (14)1.275 USD
Vol Ratio (20d)1.42x

About Carl Zeiss Meditec (ETR: AFX)

›

Carl Zeiss Meditec (ETR: AFX) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 5,784 employees.

The shares were at 32.26 EUR on 19 November 2026, down 20.3% over 52 weeks. Its 52-week range is 22.62 EUR to 46.54 EUR: the price is 30.7% below the high and 42.6% above the low.

At a market capitalisation of 2.82B EUR, it trades at 23.2 times trailing earnings and 22.1 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 53% for AFX. It pays a dividend yielding 1.60% (it pays out 40% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Carl Zeiss Meditec reports return on equity of 6.7%, an operating margin of 7.2% and revenue up 2.4% year over year.

Its debt exceeds its cash by 557.06M EUR, a debt-to-equity ratio of 0.06. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 15 analysts cover the stock, with an average rating of Underperform; their mean price target of 26.86 EUR is 16.7% below the current price. The next earnings report is expected on 10 December 2026.